Response to Abemaciclib and Immunotherapy Rechallenge with Nivolumab and Ipilimumab in a Heavily Pretreated TMB-H Metastatic Squamous Cell Lung Cancer with CDKN2A Mutation, PIK3CA Amplification and TPS 80%: A Case Report
Dias E Silva, Douglas, Borba, Guilherme Bes, Beal, Juliana Rodrigues, Botrus, Gehan, Osawa, Akemi, Araújo, Sérgio Eduardo Alonso, Moura, Fernando, Guendelmann, Rafael Aliosha Kaliks, Uson Junior, Pedro Luiz Serrano
Published in International journal of molecular sciences (01.02.2023)
Published in International journal of molecular sciences (01.02.2023)
Get full text
Journal Article